We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biomarker-based Companion Diagnostics Are Enabling Precision Oncology

Video   Sep 17, 2019 | by OriGene Technologies Inc.

 

Clinical trials are underway to examine the efficacy of various immune checkpoint inhibitor molecules, for the treatment of cancer.

Watch this video to learn about the companion diagnostics that are enabling the identification of patients who could benefit from these treatments.

 
More Information
 
 
 

Recommended Videos

Decoding Cancer Immunology: Hunting Hidden Tumors

Video

The immune system is constantly on the lookout for threats, but cancer isn’t always easy to spot. Some cancer cells can fly under the radar. Now, advanced sequencing technologies are enabling scientists to investigate the unique genetics of both cancers and immune responses in individual patients. This means researchers can develop treatments that boost the immune system and help the body win its battle against cancer.

WATCH NOW

Rapid Triage Test for Active Pulmonary Tuberculosis

Video

A team of researchers from the Wyss Institute for Biologically Inspired Engineering, The Broad Institute of Harvard and MIT, Brigham and Women’s Hospital (BWH), and several other collaborating institutions have created a fast, ultrasensitive, multiplexed diagnostic TB test, that could be used in low-resource settings.

WATCH NOW

Genetics Is Shaping Agriculture and Food

Video

When CRISPR, the gene manipulation tool, is used on crops’ DNA, it can become a powerful way to program plants’ response to pathogen attacks.

WATCH NOW

 

Like what you just watched? You can find similar content on the communities below.

Biopharma Cancer Research Diagnostics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE